Search Results - "Giri, P G"

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 by Al-Sarraf, M, LeBlanc, M, Giri, P G, Fu, K K, Cooper, J, Vuong, T, Forastiere, A A, Adams, G, Sakr, W A, Schuller, D E, Ensley, J F

“…The Southwest Oncology Group (SWOG) coordinated an Intergroup study with the participation of Radiation Therapy Oncology Group (RTOG), and Eastern Cooperative…”
Get full text

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 by Al-Sarraf, M, LeBlanc, M, Giri, P G, Fu, K K, Cooper, J, Vuong, T, Forastiere, A A, Adams, G, Sakr, W A, Schuller, D E, Ensley, J F

“…The Southwest Oncology Group (SWOG) coordinated an Intergroup study with the participation of Radiation Therapy Oncology Group (RTOG), and Eastern Cooperative…”
Get more information

Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216) by Adelstein, David J., Moon, James, Hanna, Ehab, Giri, P. G. Shankar, Mills, Glenn M., Wolf, Gregory T., Urba, Susan G.

“…Background In an effort to optimize nonoperative therapy in patients with locoregionally advanced head and neck squamous cell cancer, the Southwest Oncology…”
Get full text

Organ Preservation for Advanced Resectable Cancer of the Base of Tongue and Hypopharynx: A Southwest Oncology Group Trial by Urba, Susan G, Moon, James, Giri, P G Shankar, Adelstein, David J, Hanna, Ehab, Yoo, George H, Leblanc, Michael, Ensley, John F, Schuller, David E

“…The Southwest Oncology Group designed a phase II trial for patients with base of tongue or hypopharyngeal cancer to evaluate the complete histologic response…”
Get full text

Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin–etoposide and daily thoracic radiotherapy in limited small-cell lung cancer by Thomas, Charles R, Giroux, Dorothy J, Janaki, Lalitha M, Turrisi, Andrew T, Crowley, John J, Taylor, Sarah A, McCracken, J.Dean, Shankir Giri, P.G, Gordon, William, Livingston, Robert B, Gandara, David R

“…Purpose: To report the long-term follow-up of Southwest Oncology Group-8269, a phase II North American cooperative group trial of concurrent cisplatin,…”
Get full text

Outcomes utilizing intensity‐modulated radiotherapy in oropharyngeal cancers: Tonsils versus base of tongue by Kanakamedala, Madhava R., Giri, Shankar P. G., Hamilton, Robert D., Bhanat, Eldrin, Vijayakumar, Srinivasan

“…Background The purpose of this study was to present the outcomes of oropharyngeal cancers treated with intensity‐modulated radiotherapy (IMRT) especially the…”
Get full text

Concurrent chemotherapy and radiation therapy in advanced head and neck cancer by Shankar Giri, P G, Taylor, S A

“…A combination of radiation therapy and cis-platinum (25 mg/m2 i.v.) day 1, vincristine (1 mg i.v.) day 2, and bleomycin (15 U i.v.) day 4 was given…”
Get more information

Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study by McCracken, J D, Janaki, L M, Crowley, J J, Taylor, S A, Giri, P G, Weiss, G B, Gordon, Jr, W, Baker, L H, Mansouri, A, Kuebler, J P

“…The Southwest Oncology Group (SWOG) has conducted a phase II study to explore the efficacy and toxicity of initial, concurrent use of radiation therapy with…”
Get more information

Computed tomography in the management of bladder carcinoma by Giri, P G, Walsh, J W, Hazra, T A

“…Between 1978 and 1980, 30 patients were evaluated by computed tomography (CT). CT differed from clinical stage in 10 of 30 patients (30%). In 9 of the 10…”
Get more information

Transoral Carbon Dioxide Laser Supraglottic Laryngectomy and Irradiation in Stage I, II, and III Squamous Cell Carcinoma of the Supraglottic Larynx: Report of Southwest Oncology Group Phase 2 Trial S9709 by Agrawal, Amit, Moon, James, Davis, R. Kim, Sakr, Wael A, Giri, Shankar P. G, Valentino, Joseph, LeBlanc, Michael, Truelson, John M, Yoo, George H, Ensley, John F, Schuller, David E

“…OBJECTIVE To evaluate feasibility, functional outcome, and disease control of endoscopic surgery and irradiation in patients with squamous cell carcinoma of…”
Get full text

Radiation therapy for early glottic carcinomas by Giri, P G, Reddy, E K, Mansfield, C M

“…From 1973 to 1978, 30 cases of early glottic cancers (TINOMO) were treated in the Department of Radiation Therapy, University of Kansas Medical Center. All 30…”
Get more information

Univariate and multivariate statistical analysis of high-grade gliomas: the relationship of radiation dose and other prognostic factors by Miller, P J, Hassanein, R S, Giri, P G, Kimler, B F, O'Boynick, P, Evans, R G

“…Univariate and multivariate statistical analyses were used to examine the relationships between duration of survival and multiple variables in the presentation…”
Get more information

Cancers of the maxillary sinus by Giri, P G

“…Maxillary sinus cancers are rare as compared with cancers of other sites. Because the onset is insidious, they are at an advanced stage at diagnosis and…”
Get more information

Dosimetric analysis in brachytherapy of carcinoma of the cervix by Krishnan, L, Cytacki, E P, Wolf, C D, Reddy, E K, Gemer, L S, Giri, P G, Smalley, S R, Evans, R G

“…Brachytherapy plays an essential role in the definitive radiation treatment of cervical carcinoma. The dosimetry of intracavitary irradiation is complex in…”
Get more information

Accelerated fractionation radiation therapy for advanced squamous cell carcinoma of the head and neck by Giri, P G, Gemer, L S

“…We treated 14 patients who had advanced head and neck cancer with an accelerated fractionation schedule of irradiation consisting of two fractions given 6…”
Get more information

S0216: A Southwest Oncology Group (SWOG) phase II trial of docetaxel (T), cisplatin (P), and fluorouracil (F) induction followed by accelerated fractionation/concomitant boost (AF/CB) radiotherapy (RT) and concurrent cisplatin for advanced head and neck squamous cell cancer (HNSCC) by Adelstein, D. J., Moon, J., Hanna, E., Shankar Giri, P. G., Mills, G. M., Wolf, G. T., Urba, S. G.

“…Abstract only 6014 Background: Randomized trials have suggested benefit from three-drug taxane-containing induction chemotherapy, and from AF/CB RT in patients…”
Get full text

Comparison of single, fractionated and hyperfractionated irradiation on the development of normal tissue damage in rat lung by Giri, P G, Kimler, B F, Giri, U P, Cox, G G, Reddy, E K

“…The effect of fractionated thoracic irradiation on the development of normal tissue damage in rats was compared to that produced by single doses. Animals…”
Get more information

A unique nasopharynx brachytherapy technique by Wolf, C D, Giri, P G, Cytacki, E P

“…To deliver a curative dose of radiation therapy to the nasopharynx using either external beam radiotherapy or conventional brachytherapy, it is often necessary…”
Get more information

Hyperfractionation protects against long-term fibrosis in rat lung by Giri, P G, Kimler, B F, Giri, U P, Cox, G G

Get full text

CNS irradiation in small cell lung cancer by Giri, P G

Get more information